CREO MEDICAL (Germany) Market Value
1RC Stock | EUR 0.21 0.01 4.55% |
Symbol | CREO |
Please note, there is a significant difference between CREO MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if CREO MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CREO MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CREO MEDICAL 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CREO MEDICAL's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CREO MEDICAL.
11/05/2024 |
| 01/04/2025 |
If you would invest 0.00 in CREO MEDICAL on November 5, 2024 and sell it all today you would earn a total of 0.00 from holding CREO MEDICAL GRP or generate 0.0% return on investment in CREO MEDICAL over 60 days. CREO MEDICAL is related to or competes with FORMPIPE SOFTWARE, Take Two, Singapore Telecommunicatio, T-Mobile, CPU SOFTWAREHOUSE, GEELY AUTOMOBILE, and Guidewire Software. More
CREO MEDICAL Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CREO MEDICAL's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CREO MEDICAL GRP upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.08) | |||
Maximum Drawdown | 21.76 | |||
Value At Risk | (5.56) | |||
Potential Upside | 6.25 |
CREO MEDICAL Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CREO MEDICAL's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CREO MEDICAL's standard deviation. In reality, there are many statistical measures that can use CREO MEDICAL historical prices to predict the future CREO MEDICAL's volatility.Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.37) | |||
Total Risk Alpha | (0.43) | |||
Treynor Ratio | (0.47) |
CREO MEDICAL GRP Backtested Returns
CREO MEDICAL GRP secures Sharpe Ratio (or Efficiency) of -0.0126, which signifies that the company had a -0.0126% return per unit of risk over the last 3 months. CREO MEDICAL GRP exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CREO MEDICAL's Risk Adjusted Performance of (0.05), standard deviation of 4.86, and Mean Deviation of 2.89 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CREO MEDICAL's returns are expected to increase less than the market. However, during the bear market, the loss of holding CREO MEDICAL is expected to be smaller as well. At this point, CREO MEDICAL GRP has a negative expected return of -0.0547%. Please make sure to confirm CREO MEDICAL's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if CREO MEDICAL GRP performance from the past will be repeated in the future.
Auto-correlation | -0.78 |
Almost perfect reverse predictability
CREO MEDICAL GRP has almost perfect reverse predictability. Overlapping area represents the amount of predictability between CREO MEDICAL time series from 5th of November 2024 to 5th of December 2024 and 5th of December 2024 to 4th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CREO MEDICAL GRP price movement. The serial correlation of -0.78 indicates that around 78.0% of current CREO MEDICAL price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.78 | |
Spearman Rank Test | -0.67 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
CREO MEDICAL GRP lagged returns against current returns
Autocorrelation, which is CREO MEDICAL stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CREO MEDICAL's stock expected returns. We can calculate the autocorrelation of CREO MEDICAL returns to help us make a trade decision. For example, suppose you find that CREO MEDICAL has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
CREO MEDICAL regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CREO MEDICAL stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CREO MEDICAL stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CREO MEDICAL stock over time.
Current vs Lagged Prices |
Timeline |
CREO MEDICAL Lagged Returns
When evaluating CREO MEDICAL's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CREO MEDICAL stock have on its future price. CREO MEDICAL autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CREO MEDICAL autocorrelation shows the relationship between CREO MEDICAL stock current value and its past values and can show if there is a momentum factor associated with investing in CREO MEDICAL GRP.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in CREO Stock
CREO MEDICAL financial ratios help investors to determine whether CREO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREO with respect to the benefits of owning CREO MEDICAL security.